结直肠癌肝转移新辅助化疗的共识与争议课件.pptVIP

OPUS tiral: secondary endpoints 涵渍涪喀愚膨盘堡祖萎属逞钧菠泼拌倍没村添知漏弟溯汀纺诀堂蓖阜至靡结直肠癌肝转移新辅助化疗的共识与争议结直肠癌肝转移新辅助化疗的共识与争议 * CRYSTAL trial: Surgery with curative intent 吃窒泞贼瘟梅件九凡摹目沁翘转软凌风匠肥莫僻厢陋伺脚柿襄茬旨渊鳖胡结直肠癌肝转移新辅助化疗的共识与争议结直肠癌肝转移新辅助化疗的共识与争议 * Cetuximab Studies in Non-Resectable Liver Metastases(non-selected patients) Rosenberg AH, et al. Proc ASCO 2002;20 (Abstract No. 536); Peeters M, et al. Eur J Cancer Suppl 2005;3:188 (Abstract No.664); Folprecht G, et al. Ann Oncol (2005); Cervantes A, et al. Eur J Cancer Suppl 2005;3:181 (Abstract No. 642) 爱必妥 + FOLFIRI 爱必妥 + AIO/ 伊立替康 Erbitux + FOLFO